Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Mitotically active cellular fibroma of the ovary: a case report and a review of the literature
1Department of Gynaecology, Nanjing Medical University Affiliated Nanjing Hospital (Nanjing First Hospital), Nanjing
2Department of Pathology, Nanjing Medical University Affiliated Nanjing Hospital (Nanjing First Hospital), Nanjing
3Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, (P.R. China)
*Corresponding Author(s): J. Wu E-mail: drwuhui@hotmail.com
Mitotically active cellular fibroma (MACF) is characterized by increased cellularity, mitotic activity, and less frequently, nuclear atypia, which comprises 10% of ovarian fibromatous tumors. The authors report the case of a 76-year-old woman who presented at the present hospital with a two-month pelvic mass. B ultrasound disclosed a 75 × 52 × 41 mm mass in the right accessories. A hysterectomy and bilateral salpingo-oophorectomy was performed. Histologically, the tumor was composed of a densely cellular proliferation of fibrolastic-like cells with bland nuclear features and arranged in a fascicular pattern. There were more than four mitotic figures per ten high-power fields (HPFs). The histological diagnosis for the mass of the right ovary was MACF. MACF should be distinguished from ovarian fibrosarcoma. MACF is a recent histopathologic entity. Despite the high count of mitotic figures, the clinical course of the tumor is typically uneventful. Long-term clinical follow-up is recommended.
Ovary; fibroma; Mitotically active cellular fibroma; Outcome.
H. Wu,J. Xie,W. Huang,J. Wu. Mitotically active cellular fibroma of the ovary: a case report and a review of the literature. European Journal of Gynaecological Oncology. 2014. 35(1);81-83.
[1] Irving J.A., McCluggage W.G.: “Ovarian spindle cell lesions: a review with emphasis on recent developments and differential diagnosis”. Adv. Anat. Pathol., 2007, 14, 305.
[2] Irving J. A., Alkushi A., Young R. H., Clement P. B.: “Cellular fibroma of the ovary. A study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma”. Am. J. Surg. Pathol., 2006, 30, 929.
[3] Kaku S., Takeshima N., Akiyama F., Furuta R., Hirai Y., Takizawa K.: “A unique fibrous tumor of the ovary. Fibrosarcoma or mitotically active cellular fibroma?”. Anticancer. Res., 2007, 27, 4365.
[4] Bucella D., Limbosch J., Buxant F., Simon P., Fayt I., Anaf V., No l JC.: “Recurrence of mitotically active cellular fibroma of the ovary”. Obstet. Gynecol. Int., 2009, 2009, 803062. doi: 10.1155/2009/803062. Epub 2009 Jan 12.
[5] Monterio S.B., Costa A., Paiva V.: “ Mitotically active cellular ovarian fibroma with Meigs syndrome and elevated CA-125. Towards fertility preservation”. Pediatr. Adolesc. Gynecol., 2012, 25, e107.
[6] Prat J., Scully R. E.: “Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases”. Cancer, 1981, 47, 2663.
[7] Tsuji T., Kawauchi S., Utsunomiya T., Nagata Y., Tsuneyoshi M.: “ Fibrosarcoma versus cellular fibroma of the ovary: a comparative study of their proliferative activity and chromosome aberrations using MIB-1 immunostaining, DNA flow cytometry, and fluores-cence in situ hybridization”. Am. J. Surg. Pathol., 1997, 21, 52.
[8] Huang Y. C., Hsu K. F., Chou C. Y., Dai Y. C., Tzeng C. C.: “Ovarian fibrosarcoma with long-term survival: a case report”. Int. J. Gynecol. Cancer., 2001, 11, 331.
[9] Cinel L., Taner D., Nabaei S. B., Oquz S., Gökmen O.: “Ovarian fibrosarcoma with five-year survival: a case report”. Eur. J. Gynaecol. Oncol., 2002, 23, 345.
[10] Choi W. J., Ha M. T., Shin J. K., Lee J. H.: “Primary ovarian fibrosarcoma with long-term survival: a report of two cases”. J. Obstet. Gynaecol. Res., 2006, 32, 524.
Web of Science (WOS) (On Hold)
Journal Citation Reports/Science Edition
Google Scholar
JournalSeek
Top